U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. TRETTEN
  1. Approved Blood Products

STN: 125398
Proper Name: Coagulation Factor XIII A-Subunit (Recombinant)
Tradename: TRETTEN
Manufacturer: Novo Nordisk Inc
Indication:

  • Is indicated for routine prophylaxis of bleeding in patients with congenital factor XIII A-Subunit deficiency.

Product Information

Supporting Documents

Back to Top